Radhamani Suraj, Bradley Christopher, Meehan-Andrews Terri, Ihmaid Saleh K, Al-Rawi Jasim
School of Pharmacy and Applied Science, La Trobe Institute of Molecular Sciences, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, Australia.
Invest New Drugs. 2014 Jun;32(3):424-35. doi: 10.1007/s10637-014-0079-4. Epub 2014 Mar 14.
The DNA dependant protein kinase (DNA-PK) enzyme plays a major part in the repair of double stranded breaks induced by radiation and hence in the radio-resistance of tumour cells. Inhibitors of DNA-PK have been tested successfully in the past for their ability to sensitize cancer cells to the effects of radiation. Here we present a novel benzoxazine, 8-methyl-2-(morpholine-4yl)-7-(pyridine-3-methoxy)-4H-1,3-benzoxacine-4-one (LTU27) and analyse its ability to cause sensitization of lung cancer and colon cancer cells to radiation. There was a significant reduction in survival rate, increase in apoptosis and inhibition in autophosphorylation of DNA-PK and AKT1 after treating them concomitantly with both radiation and LTU27. The mechanism of action appears to be through inhibition of DNA-PK leading to delayed DNA repair and promotion of apoptosis.
DNA依赖性蛋白激酶(DNA-PK)在修复辐射诱导的双链断裂中起主要作用,因此在肿瘤细胞的放射抗性中也起主要作用。过去已经成功测试了DNA-PK抑制剂使癌细胞对辐射作用敏感的能力。在此,我们展示了一种新型苯并恶嗪,8-甲基-2-(吗啉-4-基)-7-(吡啶-3-甲氧基)-4H-1,3-苯并恶嗪-4-酮(LTU27),并分析了其使肺癌和结肠癌细胞对辐射敏感的能力。在用辐射和LTU27同时处理后,细胞存活率显著降低,细胞凋亡增加,DNA-PK和AKT1的自磷酸化受到抑制。其作用机制似乎是通过抑制DNA-PK导致DNA修复延迟并促进细胞凋亡。